Shou I - Search Results

1

Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients.

Gohda T, Shou I, Fukui M, Funabiki K, Horikoshi S, Shirato I, Tomino Y. Gohda T, et al. Among authors: shou i. Am J Kidney Dis. 2002 Jun;39(6):1255-60. doi: 10.1053/ajkd.2002.33399. Am J Kidney Dis. 2002. PMID: 12046039

2

Evaluation of parathyroid hyperplasia by ultrasonographic examination in patients with end-stage renal failure before and at initiation of dialysis.

Hamada C, Fukui M, Sakamoto T, Koizumi M, Ishiguro C, Osada S, Shou I, Hayashi K, Tomino Y. Hamada C, et al. Among authors: shou i. Nephrology (Carlton). 2003 Jun;8(3):116-20. doi: 10.1046/j.1440-1797.2003.00145.x. Nephrology (Carlton). 2003. PMID: 15012726

3

Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.

Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y. Zheng Y, et al. Among authors: shou i. J Nephrol. 2002 Jan-Feb;15(1):36-41. J Nephrol. 2002. PMID: 11936424

4

Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine.

Shimizu-Tokiwa A, Kobata M, Io H, Kobayashi N, Shou I, Funabiki K, Fukui M, Horikoshi S, Shirato I, Saito K, Tomino Y. Shimizu-Tokiwa A, et al. Among authors: shou i. Nephron. 2002 Sep;92(1):224-6. doi: 10.1159/000064453. Nephron. 2002. PMID: 12187109

5

Pharmacokinetics of calcitriol and maxacalcitol administered into peritoneal dialysate bags in peritoneal dialysis patients.

Hamada C, Hayashi K, Shou I, Inaba M, Ro Y, Io H, Maeda K, Fukui M, Tomino Y. Hamada C, et al. Among authors: shou i. Perit Dial Int. 2005 Nov-Dec;25(6):570-5. Perit Dial Int. 2005. PMID: 16411524

6

Usefulness of a body composition analyzer, InBody 2.0, in chronic hemodialysis patients.

Okamoto M, Fukui M, Kurusu A, Shou I, Maeda K, Hamada C, Tomino Y. Okamoto M, et al. Among authors: shou i. Kaohsiung J Med Sci. 2006 May;22(5):207-10. doi: 10.1016/S1607-551X(09)70237-2. Kaohsiung J Med Sci. 2006. PMID: 16793554 Free article.

7

Detection of antioxidant enzyme activities in renal tissues of early stage IgA nephropathy in ddY mice.

Wang LN, Fukui M, Shou I, Yaguchi Y, Funabiki K, Horikoshi S, Shirato I, Tomino Y. Wang LN, et al. Among authors: shou i. J Clin Lab Anal. 1996;10(6):394-8. doi: 10.1002/(SICI)1098-2825(1996)10:6<394::AID-JCLA13>3.0.CO;2-S. J Clin Lab Anal. 1996. PMID: 8951608

8

Serum levels of soluble Fas and disease activity in patients with IgA nephropathy.

Shou I, Tashiro K, Kurusu A, Kaneko S, Hayashi T, Fukui M, Shirato I, Kubota K, Tomino Y. Shou I, et al. Nephron. 1999;81(4):387-92. doi: 10.1159/000045321. Nephron. 1999. PMID: 10095173 Clinical Trial.

9

Correlations among expression of glomerular intercellular adhesion molecule 1 (ICAM-1), levels of serum soluble ICAM-1, and renal histopathology in patients with IgA nephropathy.

Nguyen TT, Shou I, Funabiki K, Shirato I, Kubota K, Tomino Y. Nguyen TT, et al. Among authors: shou i. Am J Nephrol. 1999;19(4):495-9. doi: 10.1159/000013505. Am J Nephrol. 1999. PMID: 10460941

10

Long-term effects of the oral adsorbent, AST-120, in patients with chronic renal failure.

Maeda K, Hamada C, Hayashi T, Shou I, Wakabayashi M, Fukui M, Horikoshi S, Tomino Y. Maeda K, et al. Among authors: shou i. J Int Med Res. 2009 Jan-Feb;37(1):205-13. doi: 10.1177/147323000903700125. J Int Med Res. 2009. PMID: 19215692 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters